President Trump announced he is withdrawing the previous nomination for the next US surgeon general and tapping Dr Nicole ...

Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with HF across the ejection fraction (EF) spectrum.

The US Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials.

Fixed-pressure PAP using manual titration is more effective than auto-adjusting PAP for blood pressure control in hypertensive patients with OSA.

Pharmacogenomics-guided regimens improve BP control and optimize medication usage in patients with hypertension without increasing adverse events.

Simultaneous heart-kidney transplantation offers better long-term survival than isolated heart transplantation for patients ...

Obesity, hypertension, hyperlipidemia, obstructive sleep apnea, and hypothyroidism are independent metabolic risk factors for MASLD.

Among patients with AAV who develop DAH, a subset also experience VTE, highlighting the complex care required to manage this population.

The FULCRUM-VT trial evaluated the clinical utility of ultra-low temperature ablation for treating ventricular tachycardia in ...

Individuals with incident CVD events had lower cognitive function starting 3 to 8 years before the event. HealthDay News — For older adults, deterioration in cognitive function is seen prior to ...

DMR may offer a safe, effective, and lasting way to maintain drug-free weight loss following GLP-1 RA discontinuation.

Longer 24-hour systolic blood pressure time-in-target range is associated with a reduced risk for all-cause and cardiovascular mortality.